Diabetes mellitus (DM) has been associated with an increased risk of colorectal cancer (CRC). The American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 recommend that clinicians be aware of an increased CRC risk in patients with smoking and obesity, but do not highlight the increase in CRC risk in patients with DM. To provide an updated quantitative assessment of the association of DM with colon cancer (CC) and rectal cancer (RC), we conducted a metaanalysis of case -control and cohort studies. We also evaluated whether the association varied by sex, and assessed potential confounders including obesity, smoking, and exercise.
INTRODUCTION
Approximately 76,000 men and 72,000 women were diagnosed with cancer of the colon and rectum in the United States in 2009, and 49,900 died from this disease ( 1 ). Colorectal cancer (CRC) is the fourth most common cancer in the United States ( 2 ) , and fourth in men and third in women worldwide ( 3 ) . Understanding the risk factors for this disease is integral to the development of eff ective strategies for the prevention of CRC. Th e risk of developing CRC is infl uenced by both genetic and acquired risk factors. Acquired risk factors associated with CRC identifi ed in prior studies include ( 4 ) the following: (i) dietary factors, such as low intake of fruit, vegetables, or fi ber, and high intake of red meat, saturated fat, caff eine, or alcohol ( 5 -9 ); (ii) lifestyle factors, such as lack of exercise, smoking, and obesity ( 10 -12 ) ; (iii) side eff ects of some medical or surgical interventions, such as pelvic irradiation, cholecystectomy, and ureterocolic anastomosis ( 13 -16 ) ; (iv) comorbid medical conditions such as Barrett ' s esophagus, human immunodefi ciency virus infection, diabetes mellitus (DM), acromegaly, and infl ammatory bowel disease ( 17 -21 ) . Th ese conditions may either directly modify risk (e.g., diet) or may serve as personal markers of altered risk through shared genetic or environmental exposures, separate from any direct mechanistic link (e.g., Barrett ' s esophagus).
In 1910, Maynard ( 22 ) provided one of the earliest reports on the association between DM and cancer. Recently, a series of studies and meta-analyses confi rmed that the risk for several solid and hematological malignancies (including liver, pancreas, colorectal, kidney, bladder, endometrial and breast cancers, and non-Hodgkin ' s lymphoma) is elevated in diabetic patients ( 23 ) . In 1984, Williams et al. ( 24 ) published a retrospective analysis of three patient populations and documented a statistically signifi cant, over 2-fold increase in the prevalence of overt DM in CRC patients compared with age-matched controls. Th e search for a pathological explanation for this connection has led to the so-called hyperinsulinemia hypothesis. Giovannucci ( 25 ) hypothesized that insulin, an important growth factor, may at high serum concentrations increase the risk of CRC by promoting growth of colon tumors, and acting as a cell mitogen. Other proposed explanations for the increased risk include decreased bowel transit time and elevated fecal concentrations of bile acids ( 26, 27 ) . Yang et al. ( 28 ) showed that insulin treatment may further elevate risk for CRC among patients with type 2 DM.
Although there is some heterogeneity in the published literature regarding the association between DM and CRC, a meta-analysis by Larsson et al. ( 19 ) in 2005 showed a relationship between DM and increased risk of CRC in both women and men by combining relative risk (RR) of colon cancer (CC) and rectal cancer (RC) (summary RR of CRC incidence 1.30, 95 % confi dence interval (CI) 1.20 -1.40). Th ey also did subgroup analyses and identifi ed elevated summary RRs of CC (summary RR 1.43, 95 % CI 1.28 -1.60; n = 7 studies) and RC (summary RR 1.33, 95 % CI 1.14 -1.54; n = 7 studies). CRC has been historically considered together; however, it is increasingly being recognized that diff erences in etiology and risk may exist between right CCs, left CCs, and RCs ( 29, 30 ) . Since the previous meta-analysis, several new studies have published separate data for CC and RC.
Th e American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 recommend that clinicians be aware of an increased risk of CRC in cigarette smokers and obese patients ( 31 ), but do not highlight the increased risk in patients with DM. Obesity and smoking are associated with the incidence of both type 2 DM and CRC ( 12,32 -34 ) ; thus, they also could be important positive confounders of the association between DM and CRC. Th e previous meta-analysis by Larsson et al. ( 19 ) did not specifi cally evaluate for these confounders.
To provide an updated quantitative assessment of the association of DM with CC and RC risk, we conducted a meta-analysis of case -control and cohort studies. We evaluated whether the association varied by sex and study design, and calculated summary RRs separately for CC ( n = 14 studies) and RC ( n = 12 studies). We also provide the fi rst meta-analysis to quantitatively assess the eff ect of certain potentially important confounding variables including obesity, smoking, and physical exercise.
METHODS

Search strategy
We identifi ed studies by a literature search of the EMBASE and MEDLINE databases (from inception through 31 December 2009) for English-language studies with the following medical subject heading terms and / or text words: " diabetes mellitus, " " diabetes, " " colorectal cancer, " " colorectal neoplasm, " " colon cancer, " " colon neoplasm, " " rectal cancer, " " rectal neoplasm, " and " risk factor. " We also reviewed reference lists of the identifi ed publications for additional pertinent studies.
Inclusion and exclusion criteria
Only reports fulfi lling the following inclusion criteria were included in the meta-analysis. First, studies were included only if they reported an estimate of RR of colon and / or RC in individuals with DM compared with individuals without DM, with a corresponding measure of uncertainty (i.e., 95 % CI, standard error, variance, or P value). Studies reporting only RR for CRC were excluded. Studies were also excluded if the estimates were not adjusted by age. Second, we included case -control studies or cohort studies published as original articles; cross-sectional, ecological, and prevalence studies were excluded. Th ird, only studies that included distinct cohorts of patients were included. For multiple reports on the same population or subpopulation, we considered the estimates from the most recent report or the one containing the most cases.
Data extraction
Th e data extracted included publication data (the fi rst author ' s last name, year of publication, and country of the population studied), study design, number of cases, number of exposed and unexposed subjects (cohort studies), number of controls and the source of the controls (case -control studies), follow-up period (for cohort studies), type of DM (type 1 or 2), risk estimates with their corresponding CIs, and variables controlled for by matching or in the multivariable models. Abstractions of the data elements and the assessment of methodological quality (see below) were conducted separately by two authors (HY and CS); discordant results were resolved by consensus.
Assessment of methodological quality
We assessed the methodological " quality " of included studies based on the Newcastle-Ottawa Scale ( 35 ) for quality of casecontrol studies and cohort studies in meta-analysis; for this assessment, we used the Newcastle-Ottawa Scale star system (range, 0 to 9 stars). In the current study, we considered a study awarded seven or more stars as a high-quality study, because standard validated criteria for important end points have not been established. Th e mean value for the six case -control studies and eight cohort studies assessed was 5.3 stars and 6.2 stars, respectively. A table containing the rankings for each study is shown in the Supplementary data online.
Statistical analysis
Summary RR estimates were calculated using both the fi xedeff ects inverse variance weighting method ( 36 ) and the randomeff ects method ( 37 ) . Statistical heterogeneity between studies was evaluated with Cochran ' s Q -test and the I 2 -statistic ( 38 ) . Publication bias was assessed by constructing a funnel plot and using Egger and Begg tests ( 39, 40 ) . All statistical analyses were carried out with STATA, version 11.0 (Stata Corp, College Station, TX). P values that were less than 0.05 were considered statistically signifi cant. All statistical tests were two-sided.
As it is increasingly being recognized that diff erences in etiology and risk may exist between right CCs, left CCs, and RCs ( 29,30 ), we calculated summary RRs separately for CC and RC. Too few studies provided separate data for the right and left CCs to calculate separate summary RRs for these.
In order to explore potential heterogeneity and evaluate diff erent forms of possible bias, several subgroup analyses were performed. Th ese included subgroup meta-analyses based on study design (case -control vs. cohort), sex, type of RR estimate (odds ratio, incidence rate ratio, standardized incidence ratio, and hazard ratio), and whether or not the studies adjusted for certain important potential confounders (obesity, smoking, or physical exercise).
RESULTS
Study characteristics
Detailed search steps are described in Figure 1 . Briefl y, from the initial literature search we identifi ed and screened 3,966 abstracts. Sixty-nine articles were considered of interest and full text was retrieved for detailed evaluation. References cited by all 69 studies were reviewed and two additional studies were identifi ed, for a total of 71 articles for full review. Fift y-seven of the seventyone articles did not meet the study inclusion and were excluded. Fourteen independent studies met our predefi ned inclusion criteria. Of these 14 studies, 6 were case -control studies ( 41 -46 ) and 8 were cohort studies ( Table 1 ) ( 47 -54 ) . Th ree of the cohort studies calculated incidence rate ratios as the measure of RR ( 47 -49 ) . Of the remaining fi ve cohort studies, three presented standardized incidence ratios ( 50 -52 ) and two presented hazard ratios ( 53, 54 ) . In terms of the geographical settings of the studies, seven studies were conducted in the United States and Canada, fi ve in Europe, and two in Japan. Excluded studies ( 26,55 -64 ) that reported only RR for CRC are listed in Table 2 . None of the cohort studies specifi ed whether the circumstances and methods for diagnosing CC were the same for patients with DM and without DM. Only one study (by Hu et al. ( 49 ) ) controlled for smoking, body mass index (BMI), and exercise, and also had follow-up >10 years, therefore no additional subgroup analyses were performed.
CRC incidence
Individual study results and the overall summary results are shown separately for CC and RC in Figure 2 and Figure 3 , respectively. Th e summary RR was 1.38 (95 % CI 1.26 -1.51) for the 14 studies with data on CC and 1.20 (95 % CI 1.09 -1.31) for the 12 studies with data on RC. Th ere was evidence of heterogeneity for both CC ( Q = 45.57, P value for heterogeneity = 0.002, I 2 = 51.7 % ) and RC ( Q = 25.58, P value for heterogeneity = 0.06, I 2 = 37.5 % ). Bowers et al. ( 54 ) included only smokers and excluding this study had little impact on our results. Table 3 shows the results of subgroup meta-analyses by study design, sex, and whether studies adjusted for potential confounders (obesity, smoking, and physical exercise). Th e association between DM and CC incidence was similar in case -control studies (summary RR 1.36, 95 % CI 1.22 -1.52; n = 11 studies) and cohort studies (summary RR 1.40, 95 % CI 1.23 -1.58; n = 12). Th e association between DM and RC incidence was higher in case -control studies (summary RR 1.31, 95 % CI 1.12 -1.53; n = 7) than in cohort studies (summary RR 1.16, 95 % CI 1.02 -1.31; n = 10). Th e results for CC were similar in men (summary RR 1.43, 95 % CI 1.30 -1.57; n = 11) and women (summary RR 1.35, 95 % CI 1.14 -1.53; n = 10). For RC, there was a signifi cant association between DM and cancer risk for men (summary RR 1.22, 95 % CI 1.07 -1.40; n = 8), but not for women (summary RR 1.09, 95 % CI = 0.99 -1.19; n = 8 studies).
Subgroup meta-analysis by methodological quality of the studies as ranked by the Newcastle-Ottawa Scale scale revealed a similar signifi cant positive association in both the high-quality studies (summary RR = 1.44 95 % CI 1.24 -1.66 n = 9 studies for CC, summary RR = 1.30 95 % CI 1.10 -1.54 n = 6 studies for RC) and the low-quality studies (summary RR = 1.35 95 % CI 1.21 -1.51; n = 14 Overall (I 2 = 51.7%, P = 0.002) Figure 2 . Association between diabetes and colon cancer (CC) incidence in six case -control and eight cohort studies. AC, ascending colon; C, cecum; CI, confi dence interval; DCC, distal colon cancer; ES, effect size; m, men; PCC, proximal colon cancer; w, women. 
REVIEW
Meta-Analysis Assessment of the Association of DM With CC and RC CI = 1.06 -1.54; n = 9 studies) remained. In the meta-analysis that was restricted to the fi ve publications that controlled for smoking, obesity, and physical activity ( 43, 45, 48, 49, 53 ) , the positive association of DM with CC (summary RR 1.37, 95 % CI 1.18 -1.59; n = 10 studies) and RC (summary RR 1.34 95 % CI 1.08 -1.67; n = 7 studies) also remained.
Publication bias
Visual inspection of the Begg funnel plot for both CC and RC did not show the asymmetry typically associated with publication bias ( Figure 4 ). Evidence of publication bias was also not seen with the Egger or Begg tests (Egger P = 0.27 and 0.64 for CC and RC, respectively).
DISCUSSION
Th is meta-analysis of observational studies indicates that DM is associated with increased risks of CC and RC. To our knowledge, this meta-analysis is the fi rst to show a statistically signifi cant association between DM and risks of CC and RC separately aft er controlling for obesity, smoking, and physical exercise, which are important potential confounders. Many of the odd ratios we . Th e positive association of DM with CC and RC risk did not decrease when the meta-analysis was limited to studies that controlled for smoking and BMI (summary RR for colon 1.34, 95 % CI 1.17 -1.52, and summary RR for rectum 1.28, 95 % CI 1.06 -1.54). Th is suggests that the confounding eff ect of obesity and smoking is relatively weak, and that DM appears to be an independent risk factor for CC and RC.
Statistical heterogeneity was seen in several of our analyses, and much of this is likely due to diff erences in study design, study population, defi nition of diabetes, and statistical methods (e.g., type of RR estimate). Statistical heterogeneity was lower in our analyses of studies which adjusted for BMI, smoking, and physical activity than in the analyses of studies that did not adjust for these potential confounders. Th is suggests that the lack of these adjustments in some studies accounted for much of the heterogeneity observed.
Data from several sources suggest that the association between DM and the risk of CRC is biologically plausible. Type 2 DM is associated with hyperinsulinemia. Mechanistically, insulin stimulates cell proliferation through two pathways. One pathway involves direct binding of insulin to insulin or insulin-like growth factor-1 (IGF-1) receptors, and the other pathway is via inhibition of IGF-binding proteins and the resultant increase in IGF-1 availability to the IGF receptor ( 72 ) . Th e IGF system is a potent growth regulator closely linked with carcinogenesis ( 73 ). Although not consistent across all studies, several prospective observational studies have shown an association between elevated IGF-1 levels and the risks of CRC or advanced adenoma ( 74 -78 ) . Th ese data support the notion that IGF-1 has a role in the biological pathway of colorectal neoplasia, beginning at the adenoma stage.
Several limitations of this study must be considered. All of the studies that assess the association between DM and CRC are observational studies, as an intervention study addressing this question would not be ethical or feasible. Rating the scales for strength of evidence rank the quality of evidence derived from observational studies as low, especially as compared with randomized trials ( 79 ) . However, there are several indications that despite the inherent limitations of observational studies, our fi nding that DM is associated with an increased risk of CRC may be a real association. Th ese include comparable results for diff erent study designs (casecontrol and cohort), a lack of heterogeneity among studies that adjusted for important confounders, and consistency of the results within the population-based studies, which increases the ability to generalize study results to similar large populations. Th ese results, however, should still be viewed with caution, as the magnitude of eff ect found was modest; such moderate eff ects may be due to unmeasured confounding that persists across studies.
Most of the studies reviewed did not distinguish between type 1 and type 2 DM. Type 1 accounts for 5 -10 % of all cases of diabetes and type 2 accounts for 90 -95 % of all DM cases ( 80 ) . DM duration and insulin requirement are diff erent in type 1 and type 2 DM, and this may aff ect tissue exposure to insulin in diff erent ways. If hyperinsulinemia has a role in promoting cancer initiation and identifi ed are close to 1.0; however, the very low P values show that these are unlikely due to chance ( P < 0.0001 for CC and P < 0.0001 for RC).
Th e association of DM and cancer risk was stronger for CC than for RC (summary RR 1.38, 95 % CI 1.26 -1.51 vs. summary RR 1.20, 95 % CI 1.09 -1.31, respectively). Th is diff erence may be because the proximal colon, distal colon, and rectum have diff erent embryological origins ( 65 ) . Previous studies have found subsite variations in susceptibility to carcinogens and neoplastic transformation ( 66, 67 ) . Molecular biological studies also indicate that tumor suppressor genes and point mutations and genetic instability diff er by subsite of the colorectum ( 68 -71 ) .
Type 2 DM and CC and RC share similar risk factors, including smoking and obesity ( 12,32 -34 ) . Th us, the increased risk of CC and RC associated with a history of DM could be the result of confounding by these risk factors. A meta-analysis by Botteri et al. ( 34 ) on smoking and CRC showed that the pooled risk estimate for ever vs. never smokers was 1.25 (95 % CI 1.14 -1.37), and a meta-analysis by Moghaddam progression, it might be expected that duration of DM would aff ect cancer RRs. Indeed, six studies used in this meta-analysis showed that CRC risk was higher among diabetics with longer duration of disease ( 42, 45, 47, 49, 51, 52 ) . Because almost one-third of diabetics is undiagnosed ( 81 ) , some degree of non-diff erential misclassifi cation of exposure to diabetes is likely to have occurred in the studies, included in this meta-analysis. Although the American Diabetes Association and the World Health Organization now share identical diagnostic criteria for type 2 DM, diagnostic criteria have changed over time ( 82 ) . Th e prevalence of DM can change as a function of diagnostic criteria used ( 83 ) . Th e studies used in this meta-analysis did not specify which criterion for DM was used, and in most studies the DM was selfreported. Such non-diff erential misclassifi cation of exposure would tend to underestimate the true relationship between DM and CRC.
Although some of the studies included in this meta-analysis controlled for obesity, smoking, or lack of physical activity, we were unable to control for other important potential confounders of the relationship between DM and CRC, including low intake of fruits and vegetables and high alcohol intake ( 84, 85 ) . Th ese confounders are more prevalent in individuals of lower socioeconomic status ( 86 ) . Th e lack of adjustment for socioeconomic status, diet, and alcohol consumption could contribute to a non-causal association between DM and CRC. However, alcohol intake and fruit and vegetable intake are likely correlated with obesity, smoking, and exercise. Because of these relationships, studies that adjusted for obesity, smoking, and exercise probably also, at least partially, adjusted for these other related factors. In addition, our fi nding that adjustment for obesity, smoking, and exercise had little impact on the relationship between DM and CRC suggests that further adjustment for alcohol and fruit and vegetable intake is unlikely to have a major impact on this relationship.
Th ere are ethnic diff erences in the incidence of CRC in the United States. Th e age-adjusted incidence rates for CRC (2000 -2006) are highest for blacks (both males and females), followed by non-Hispanic whites, Asian / Pacifi c Islanders, Hispanics, and American Indians / Alaska natives (SEER database) ( 1 ). Th is may distort the true relationship between DM and CRC, if these diff erences are not taken into account.
Another potential bias is detection bias. A person with DM is likely to have many more contacts with the health-care system than a person without DM. Th is might have provided more opportunities for them to have a sigmoidoscopy, colonoscopy, or fecal blood test ordered. Although the extent of this bias is unknown, it is possible that modest increases in cancer incidence could be explained solely by more intense screening in the DM group.
In this meta-analysis, no evidence of publication bias was seen in the funnel plot or in Begg or Egger tests (Egger P = 0.27 and 0.64 for CC and RC, respectively). However, it should be noted that several factors other than publication bias can aff ect the outcome of these statistical tests, and their validity and interpretation has been debated ( 87 ) .
Finally, it is widely accepted that the majority of CRCs develop slowly through polypoid growth, and endoscopists have traditionally focused on fi nding and removing polypoid adenomas -growths that protrude from the mucosa -during screening colonoscopy. Reports from Japan in the 1980s and 1990s suggested that nonpolypoid (fl at and depressed) colorectal neoplasms were common and ominous ( 88, 89 ) . Th e likelihood that nonpolypoid (fl at and depressed) colorectal neoplasms harbor serious pathology ( in situ or submucosal carcinoma) was more than fi ve times higher than the rate polypoid lesions aft er adjusting for polyp size ( 90 ) . It is only recently that the existence of nonpolypoid (fl at and depressed) colorectal neoplasm has been shown to contribute to the development of CRC ( 91 ) . As a result, many endoscopists may not be aware of the subtle features of these lesions. Furthermore, one study indicated that diabetic patients (irrespective of insulin use, diabetic control, or diabetic neuropathy) have a signifi cantly poorer response to a colonoscopy bowel cleansing preparations than do nondiabetic patients ( 92 ) . A recent study also suggests that optimal bowel preparation was signifi cantly poorer in DM patients with autonomous neuropathy than in DM patients without autonomous neuropathy and controls ( 93 ) . Th e diagnostic accuracy of the colonoscopy depends on the quality of the colon cleansing. If patients with DM are less likely to have precancerous polyps removed on colonoscopy, this may increase their risk of subsequent cancer over long periods of time. Conversely, if poor preparations lead to decreased cancer detection on short-term studies, this could underestimate the true relationship between DM and CRC.
Our results have important clinical and public health implications. Th e results from this meta-analysis suggest that DM is an independent risk factor of CC and RC. Although observational studies cannot exclude confounding as an explanation, especially when eff ect sizes are modest to moderate, the consistency of the evidence suggests a potential role for hyperinsulinemia or factors related to insulin resistance in colorectal carcinogenesis. Other data suggest that chronic insulin therapy is associated with increased colorectal adenoma risk among type 2 DM patients. Th ese results may suggest a need for more intensive CRC screening program in patients with type 2 DM, especially those who receive chronic insulin therapy ( 94 ) .
In the United States, about 23.6 million people or 7.8 % of adults have DM ( 95 ) , and by 2050, the number of people in the United States with diagnosed DM is estimated to grow to 48.3 million ( 80 ) . Furthermore, as a recent study indicated, persons with DM and CRC may be at increased risk for CRC recurrence, non-response to chemo and radiotherapy treatment, and treatment-related complications ( 96 ) . CRC deaths may be reduced through CRC screening programs. We encourage the American College of Gastroenterology to review CRC screening guidelines to determine whether diabetic status should be included as a risk factor that warrants changes in screening frequency or intensity. We also recommend that future studies on the association between DM and CRC focus on plausible causal mechanisms or mediating factors, such as obesity, smoking, physical activity, diagnostic bias, duration of diabetes, and antidiabetic therapy.
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